Literature DB >> 36111096

Octreotide to treat severe hypoglycaemia in Guillain-Barre syndrome.

Sangeetha R Palaniswamy1, Bharath Srinivasaiah1, Sudhir Venkataramaiah1.   

Abstract

Entities:  

Year:  2022        PMID： 36111096      PMCID： PMC9468996          DOI： 10.4103/ija.ija_946_21

Source DB:  PubMed          Journal:  Indian J Anaesth        ISSN： 0019-5049


× No keyword cloud information.
  5 in total

Review 1.  Neurologic damage in hypoglycemia.

Authors:  Simin Mohseni
Journal:  Handb Clin Neurol       Date:  2014

Review 2.  Autonomic involvement in Guillain-Barré syndrome: an update.

Authors:  Zoya Zaeem; Zaeem A Siddiqi; Douglas W Zochodne
Journal:  Clin Auton Res       Date:  2018-07-17       Impact factor: 4.435

Review 3.  Hypoglycemia-associated autonomic failure, counterregulatory responses, and therapeutic options in type 1 diabetes.

Authors:  Michael R Rickels
Journal:  Ann N Y Acad Sci       Date:  2019-08-06       Impact factor: 5.691

4.  Intra-operative carcinoid crisis: Revised anaesthesia management.

Authors:  Michelle L Kromas; Yuvesh Passi; Chika Kuzumi; Soni Shikhar
Journal:  Indian J Anaesth       Date:  2017-05

5.  Successful Use of Octreotide Therapy for Refractory Levofloxacin-Induced Hypoglycemia: A Case Report and Literature Review.

Authors:  Matthew R Watson; Ceressa T Ward; Amit Prabhakar; Babar Fiza; Vanessa Moll
Journal:  Case Rep Crit Care       Date:  2019-05-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.